Elekta wins lawsuit against Livian GmbH

STOCKHOLM,March 8,2021 -- Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration,reported in the latest interim report (Q3 2020/21),is now finally settled whereby all claims against Elekta group companies are rejected in full.

For further information,please contact:

Mattias Thorsson,VP Corporate Communications

Tel: +46 70 865 8012,e-mail:Mattias.Thorsson@elekta.com

Time zone: CET: Central European Time

Cecilia Ketels,Head of Investor Relations

Tel: +46 76 611 76 25,e-mail: cecilia.ketels@elekta.com

Time zone: CET: Central European Time

About Elekta

For almost five decades,Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise,personalized radiotherapy treatments. Headquartered in Stockholm,Sweden,Elekta is listed on NASDAQ Stockholm Exchange. Visitelekta.comor follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-wins-lawsuit-against-livian-gmbh,c3301556

The following files are available for download:

https://mb.cision.com/Main/35/3301556/1383413.pdf

Release